(Reuters) – Chinese startup DeepSeek said on Monday it is temporarily limiting registrations due to a large-scale malicious attack on its services. (Reporting by Arsheeya Bajwa in Bengaluru; Editing by Shilpi Majumdar)
By Colleen Howe BEIJING (Reuters) – China’s mostly coal-based thermal power generation is set to fall in 2025 for the first time in a decade, some analysts estimate, though they caution that extreme weather or stronger than expected industrial growth could upend that forecast. That would be a positive signal for the decarbonisation of China’s …
China’s fossil-fuelled power output may fall in 2025 for first time in decade Read More »
(Reuters) – Tesla investors will look for more details on the automaker’s lower-priced model when it reports quarterly results on Wednesday as some expect the cheaper car to help the company hit its goal to increase deliveries by up to 30% this year. The world’s most valuable automaker has seen its stock market valuation soar …
Tesla investors pin hopes on cheaper EV model to boost sales after lackluster 2024 Read More »
BRUSSELS (Reuters) – Tesla has joined BMW and Chinese producers in filing a challenge at the Court of Justice of the European Union (CJEU) against EU tariffs on China-made electric vehicles, according to a filing on the court’s website on Monday. The challenge will open a new front in Brussels’ conflict with Elon Musk, Tesla …
Tesla joins court challenges to EU tariffs on Chinese EVs Read More »
(Reuters) -U.S. search engine startup Perplexity AI has revised the merger proposal it had submitted to TikTok’s Chinese parent ByteDance to create a new entity combining Perplexity and TikTok U.S., a person familiar with the proposal told Reuters on Sunday. The proposal calls for the U.S. government to own up to 50% of the new …
(Reuters) – The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan’s Eisai and partner Biogen’s Alzheimer’s drug Leqembi, the companies said on Monday. The drug received standard U.S. approval in 2023 after showing it slowed cognitive decline in patients with the brain-wasting disease but growth has been slow, in part because …
US FDA OKs monthly maintenance dosing for Eisai/Biogen’s Alzheimer’s drug Read More »
By Nell Mackenzie LONDON (Reuters) – Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China’s new AI model was emerging to challenge U.S. dominance in the sector, a Goldman Sachs note said. Nasdaq futures slumped and technology shares slid on Monday as the swelling popularity of …
Hedge funds were pausing US AI bets as DeepSeek emerged, says Goldman Read More »
By Ariba Shahid KARACHI, Pakistan (Reuters) -Pakistan’s central bank cut its benchmark interest rate by 100 basis points to 12% on Monday, in line with expectations, as inflation eases and growth looks to set to pick up after 1,000 basis points of rate cuts over the last six months. The State Bank of Pakistan has slashed rates from …
Pakistan central bank cuts key rate to 12% amid easing inflation Read More »
(Reuters) – China’s net gold imports via Hong Kong in December fell 84% from the previous month, dropping to their lowest since April 2022, Hong Kong Census and Statistics Department data showed on Monday. WHY IT’S IMPORTANT China is the world’s leading consumer of gold, and its purchasing activities can significantly influence global gold prices. …
China’s net gold imports via Hong Kong slump in December Read More »
BEIJING (Reuters) – China on Monday issued guidelines on strengthening supervision of trust companies, aiming to bolster risk control within the trust industry, according to a statement released on the government’s website. Under the guidelines, China will step up market access regulation and strictly review the qualification of the trust firms’ shareholders. It will also …
China issues new guidelines to strengthen supervision of trust companies Read More »
